Medpace - Rising R&D Expenditures in the Pharmaceutical and Biotech Industry Drive Strong Outlook!
Reading Time: 1 minute
Business drivers: Medpace Holdings (MEDP) is one of the world's leading Contract Research Organizations (CRO), offering services for biotech and pharmaceutical companies to support the conduct of clinical trials and the associated approval processes. This not only significantly accelerates the execution of clinical test series but also considerably reduces costs. Medpace is well-positioned in machine learning and AI tools such as Medpace Core Lab, which can quickly and reliably identify genetic defects or serious heart, liver, or tumor diseases...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
